Clinical Trial

Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum

Study acronym: PAS
Unknown
View on ClinicalTrials.gov →
Summary
The main goal of this case-control study is to quantify the levels of circulating syncytiotrophoblast-derived extracellular vesicles (STBEVs) in maternal blood in a population of women with placenta previa and placenta accreta spectrum.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06867874
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Placenta Previa, Placenta Accreta Spectrum
Enrollment 70 participants
Start Date 2023-07-10
Primary Completion 2025-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-10